|
|
|
|
Dictionary |
|
Nalpha-[(benzyloxy)carbonyl]-n-(4-fluoro-3-oxo-2-butanyl)phenylalaninamide |
(2R,3s,4r,5r)-2,3,4,5-tetrahydroxy-6-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]hexanal |
4-(2-Formylquinoline-3-carbonyl)benzoic acid |
2-[4-[Bis(carboxymethyl)amino]-3-(carboxymethoxy)phenyl]-1h-indole-6-carboxylic acid potassium salt(1:4) |
Acetyloxymethyl 2-[[2-(acetyloxymethoxy)-2-oxoethyl]-[5-[2-[2-[bis[2-(acetyloxymethoxy)-2-oxoethyl]amino]-5-methylphenoxy]ethoxy]-2-[(e)-(5-oxo-2-sulfanylideneimidazolidin-4-ylidene)methyl]-1-benzofur |
4-{6-[4-(Diethylamino)phenyl]-1,3,5-hexatrien-1-yl}-1-[3-(triethylammonio)propyl]pyridinium dibromide |
Sulforhodamine 101 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanollamine triethylammonium salt |
Docosanoic acid ethyl ester |
5,6-Dihydro-1-methyl-5,6-dioxo-2-indolinesulfonic acid 5-semicarbazone |
3-Methoxy-4,5-methylenedioxyamphetamine hydrochloride |
|
|
|
Dictionary |
|
|
Chemical Name: |
N-(4-chlorophenyl)-2-[(4-pyridinylmethyl)amino]benzamide |
Synonyms: |
N-(4-CHLOROPHENYL)-2-[(PYRIDIN-4-YLMETHYL)AMINO]BENZAMIDE;VEGF RECEPTOR TYROSINE KINASE INHIBITOR II |
CAS#: |
269390-69-4 |
Molecular formula: |
C19H16ClN3O |
Molecular weight: |
337.80 |
Molecular Structure: |
|
|
|